About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Diabetics to get Relief from Cheaper Drugs

by Medindia Content Team on August 25, 2006 at 1:28 PM
Font : A-A+

Diabetics to get Relief from Cheaper Drugs

The Federal Government's decision to list two new drugs on the Pharmaceutical Benefits Scheme will allow diabetics to have better access to treatment from October.

According to Health Minister Tony Abbott long-lasting injectable insulins Levemir and Lantus will be subsidized from October 1, at a cost of $145 million over the next three years.

Advertisement

These drugs have several medical advantages over current subsidized treatments.

Daily injections are needed by all type-one diabetics and some type-two diabetics to control their blood sugar levels.

Presently about 210,000 Australians with type one and type two diabetes will qualify for the drugs, and about 110,000 people are expected to use them in the first year of listing.
Advertisement

By 2009 about 160,000 patients are expected to benefit from this with each paying $9.40 for concession card holders and non-concessional patients paying about $59 for a year's supply.

According to Donald Chisholm, professor of endocrinology at Sydney's St Vincent's Hospital, these drugs could help to bring down the number of injections for some patients because of the longer lasting effect compared to other common insulin.

Prof Chisholm said that these drugs are absorbed slowly during the 24 hours after an injection, thereby preventing a potentially dangerous peak in insulin levels as well as lowering the risk of hypoglycaemia.
Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Diabetics to get Relief from Cheaper Drugs Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests